SOUTH
PLAINFIELD, N.J., Jan. 3, 2024
/PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today
announced that the company will present a company overview at the
42nd Annual J.P. Morgan Healthcare Conference on
Monday, Jan. 8, at 7:30 a.m. PST/10:30 a.m.
EST.
The presentations will be webcast live on the Events and
Presentations page under the Investor section of PTC Therapeutics'
website at https://ir.ptcbio.com/events-presentations and will be
archived for 30 days following the presentations. It is recommended
that users connect to PTC's website several minutes prior to the
start of the webcast to ensure a timely connection.
About PTC Therapeutics, Inc.
PTC is a science-driven, global biopharmaceutical company
focused on the discovery, development and commercialization of
clinically differentiated medicines that provide benefits to
patients with rare disorders. PTC's ability to globally
commercialize products is the foundation that drives investment in
a robust and diversified pipeline of transformative medicines and
our mission to provide access to best-in-class treatments for
patients who have an unmet medical need. The Company's strategy is
to leverage its strong scientific expertise and global commercial
infrastructure to maximize value for its patients and other
stakeholders. To learn more about PTC, please visit us at
www.ptcbio.com and follow us on Instagram, Facebook, Twitter, and
LinkedIn.
For More Information:
Investors:
Kylie
O'Keefe
+1 (908) 300-0691
kokeefe@ptcbio.com
Media:
Jeanine
Clemente
+1 (908) 912-9406
jclemente@ptcbio.com
View original
content:https://www.prnewswire.com/news-releases/ptc-therapeutics-to-participate-at-42nd-annual-jp-morgan-healthcare-conference-302024767.html
SOURCE PTC Therapeutics